228 related articles for article (PubMed ID: 28727617)
1. Granulosa Cell Tumors: Novel Predictors of Recurrence in Early-stage Patients.
Sakr S; Abdulfatah E; Thomas S; Al-Wahab Z; Beydoun R; Morris R; Ali-Fehmi R; Bandyopadhyay S
Int J Gynecol Pathol; 2017 May; 36(3):240-252. PubMed ID: 28727617
[TBL] [Abstract][Full Text] [Related]
2. Transformation in recurrent ovarian granulosa cell tumors: Ki67 (MIB-1) and p53 immunohistochemistry demonstrates a possible molecular basis for the poor histopathologic prediction of clinical behavior.
Costa MJ; Walls J; Ames P; Roth LM
Hum Pathol; 1996 Mar; 27(3):274-81. PubMed ID: 8600043
[TBL] [Abstract][Full Text] [Related]
3. HER2 and GATA4 are new prognostic factors for early-stage ovarian granulosa cell tumor-a long-term follow-up study.
Färkkilä A; Andersson N; Bützow R; Leminen A; Heikinheimo M; Anttonen M; Unkila-Kallio L
Cancer Med; 2014 Jun; 3(3):526-36. PubMed ID: 24687970
[TBL] [Abstract][Full Text] [Related]
4. Outcome of patients with recurrent adult-type granulosa cell tumors--a Taiwanese Gynecologic Oncology Group study.
Wang PH; Sun HD; Lin H; Wang KL; Liou WS; Hung YC; Chiang YC; Lu CH; Lai HC; Chang TC;
Taiwan J Obstet Gynecol; 2015 Jun; 54(3):253-9. PubMed ID: 26166336
[TBL] [Abstract][Full Text] [Related]
5. High GATA-4 expression associates with aggressive behavior, whereas low anti-Müllerian hormone expression associates with growth potential of ovarian granulosa cell tumors.
Anttonen M; Unkila-Kallio L; Leminen A; Butzow R; Heikinheimo M
J Clin Endocrinol Metab; 2005 Dec; 90(12):6529-35. PubMed ID: 16159935
[TBL] [Abstract][Full Text] [Related]
6. Recurrent granulosa cell tumors (GCTs) of the ovary: a MITO-9 retrospective study.
Mangili G; Sigismondi C; Frigerio L; Candiani M; Savarese A; Giorda G; Lauria R; Tamberi S; Greggi S; Lorusso D
Gynecol Oncol; 2013 Jul; 130(1):38-42. PubMed ID: 23623833
[TBL] [Abstract][Full Text] [Related]
7. [Granulosa cell tumor in different periods of women's life].
Chudecka-Głaz A; Rzepka-Górska I; Błogowska A; Zielińska D
Ginekol Pol; 2003 Sep; 74(9):689-94. PubMed ID: 14674109
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 are highly expressed in ovarian granulosa cell tumors.
Färkkilä A; Anttonen M; Pociuviene J; Leminen A; Butzow R; Heikinheimo M; Unkila-Kallio L
Eur J Endocrinol; 2011 Jan; 164(1):115-22. PubMed ID: 21041381
[TBL] [Abstract][Full Text] [Related]
9. The role of systemic chemotherapy in the management of granulosa cell tumors.
Meisel JL; Hyman DM; Jotwani A; Zhou Q; Abu-Rustum NR; Iasonos A; Pike MC; Aghajanian C
Gynecol Oncol; 2015 Mar; 136(3):505-11. PubMed ID: 25546114
[TBL] [Abstract][Full Text] [Related]
10. Predictors of recurrence of ovarian granulosa cell tumors.
Nosov V; Silva I; Tavassoli F; Adamyan L; Farias-Eisner R; Schwartz PE
Int J Gynecol Cancer; 2009 May; 19(4):628-33. PubMed ID: 19509561
[TBL] [Abstract][Full Text] [Related]
11. Surgical staging and adjuvant chemotherapy in the management of patients with adult granulosa cell tumors of the ovary.
Park JY; Jin KL; Kim DY; Kim JH; Kim YM; Kim KR; Kim YT; Nam JH
Gynecol Oncol; 2012 Apr; 125(1):80-6. PubMed ID: 22210469
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors of ovarian granulosa cell tumor: a study of 35 patients and review of the literature.
Auranen A; Sundström J; Ijäs J; Grénman S
Int J Gynecol Cancer; 2007; 17(5):1011-8. PubMed ID: 17374124
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with an increased risk of recurrence in women with ovarian granulosa cell tumors.
Suri A; Carter EB; Horowitz N; Denslow S; Gehrig PA
Gynecol Oncol; 2013 Nov; 131(2):321-4. PubMed ID: 23994106
[TBL] [Abstract][Full Text] [Related]
14. Contribution of lymph node staging method and prognostic factors in malignant ovarian sex cord-stromal tumors: A world wide database analysis.
Wang J; Li J; Chen R; Lu X
Eur J Surg Oncol; 2018 Jul; 44(7):1054-1061. PubMed ID: 29705285
[TBL] [Abstract][Full Text] [Related]
15. Characteristics and outcome of recurrence in molecularly defined adult-type ovarian granulosa cell tumors.
Bryk S; Färkkilä A; Bützow R; Leminen A; Tapper J; Heikinheimo M; Unkila-Kallio L; Riska A
Gynecol Oncol; 2016 Dec; 143(3):571-577. PubMed ID: 27729108
[TBL] [Abstract][Full Text] [Related]
16. FOXL2, GATA4, and SMAD3 co-operatively modulate gene expression, cell viability and apoptosis in ovarian granulosa cell tumor cells.
Anttonen M; Pihlajoki M; Andersson N; Georges A; L'hôte D; Vattulainen S; Färkkilä A; Unkila-Kallio L; Veitia RA; Heikinheimo M
PLoS One; 2014; 9(1):e85545. PubMed ID: 24416423
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant chemotherapy does not improve disease-free survival in FIGO stage IC ovarian granulosa cell tumors: The MITO-9 study.
Mangili G; Ottolina J; Cormio G; Loizzi V; De Iaco P; Pellegrini DA; Candiani M; Giorda G; Scarfone G; Cecere SC; Frigerio L; Gadducci A; Marchetti C; Ferrandina G
Gynecol Oncol; 2016 Nov; 143(2):276-280. PubMed ID: 27597380
[TBL] [Abstract][Full Text] [Related]
18. Ovarian granulosa cell tumor: A National Cancer Database study.
Seagle BL; Ann P; Butler S; Shahabi S
Gynecol Oncol; 2017 Aug; 146(2):285-291. PubMed ID: 28532858
[TBL] [Abstract][Full Text] [Related]
19. Adult ovarian granulosa cell tumors: analysis of outcomes and risk factors for recurrence.
Plett H; Ricciardi E; Vacaru V; Ramspott JP; Colombo N; Sehouli J; du Bois A; Garbi A; Richter R; Ataseven B; Aletti G; Braicu E; Heitz F; Portuesi R; Muallem MZ; Dagres T; Parma G; Roser E; Traut A; Multinu F; Harter P
Int J Gynecol Cancer; 2023 May; 33(5):734-740. PubMed ID: 36759002
[TBL] [Abstract][Full Text] [Related]
20. The association between progesterone receptor expression and survival in women with adult granulosa cell tumors.
Puechl AM; Edwards J; Suri A; Nakayama J; Bean S; Gehrig P; Saks E; Duska L; Broadwater G; Ehrisman J; Horowitz N; Secord AA
Gynecol Oncol; 2019 Apr; 153(1):74-79. PubMed ID: 30661765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
